Financial Ratios Hygeia Healthcare Holdings Co., Limited
Equities
6078
KYG4712E1035
Healthcare Facilities & Services
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
16.54 HKD | -0.36% | +3.89% | -53.14% |
Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|
Profitability | |||||||
Return on Assets | 5.32 | 5.75 | 5.77 | 6.6 | 6.05 | ||
Return on Total Capital | 6.67 | 6.44 | 6.54 | 7.7 | 7.15 | ||
Return On Equity % | -20.35 | 8.56 | 10.28 | 10.23 | 12.24 | ||
Return on Common Equity | -20.16 | 8.37 | 10.12 | 10.15 | 12.23 | ||
Margin Analysis | |||||||
Gross Profit Margin % | 30.11 | 34.25 | 32.16 | 31.83 | 31.08 | ||
SG&A Margin | 13.68 | 11.89 | 9.74 | 9.17 | 10.06 | ||
EBITDA Margin % | 22.34 | 27.49 | 26.94 | 27.18 | 25.78 | ||
EBITA Margin % | 16.68 | 22.88 | 22.88 | 23.18 | 21.49 | ||
EBIT Margin % | 16.45 | 22.7 | 22.7 | 23.02 | 21.35 | ||
Income From Continuing Operations Margin % | 3.66 | 12.63 | 19.57 | 15.08 | 16.8 | ||
Net Income Margin % | 3.66 | 12.13 | 19.07 | 14.92 | 16.75 | ||
Net Avail. For Common Margin % | 3.66 | 12.13 | 19.07 | 14.92 | 16.75 | ||
Normalized Net Income Margin | 5.09 | 11.5 | 13.38 | 13.9 | 12.79 | ||
Levered Free Cash Flow Margin | -6.27 | -12.5 | 1.33 | -6.35 | 3.9 | ||
Unlevered Free Cash Flow Margin | -0.77 | -10.35 | 1.96 | -5.67 | 4.56 | ||
Asset Turnover | |||||||
Asset Turnover | 0.52 | 0.41 | 0.41 | 0.46 | 0.45 | ||
Fixed Assets Turnover | 0.99 | 1.13 | 1.19 | 1.16 | 1.07 | ||
Receivables Turnover (Average Receivables) | 6.01 | 5.93 | 6.4 | 6 | 5.45 | ||
Inventory Turnover (Average Inventory) | 14.22 | 16.25 | 16.02 | 12.8 | 11.62 | ||
Short Term Liquidity | |||||||
Current Ratio | 0.39 | 10.4 | 2.01 | 1.71 | 1.02 | ||
Quick Ratio | 0.35 | 10.17 | 1.84 | 1.48 | 0.86 | ||
Operating Cash Flow to Current Liabilities | 0.13 | 1.05 | 0.5 | 0.67 | 0.4 | ||
Days Sales Outstanding (Average Receivables) | 60.72 | 61.76 | 57.03 | 60.87 | 66.95 | ||
Days Outstanding Inventory (Average Inventory) | 25.67 | 22.53 | 22.79 | 28.53 | 31.41 | ||
Average Days Payable Outstanding | 54.34 | 47.72 | 47.29 | 57.24 | 68.53 | ||
Cash Conversion Cycle (Average Days) | 32.06 | 36.56 | 32.53 | 32.16 | 29.83 | ||
Long Term Solvency | |||||||
Total Debt/Equity | -1K | 0.06 | 27.51 | 26.1 | 43.56 | ||
Total Debt / Total Capital | 111.07 | 0.06 | 21.57 | 20.69 | 30.34 | ||
LT Debt/Equity | -312.42 | 0.02 | 26.73 | 22.39 | 37.11 | ||
Long-Term Debt / Total Capital | 34.59 | 0.02 | 20.96 | 17.75 | 25.85 | ||
Total Liabilities / Total Assets | 109.15 | 7.66 | 33.04 | 31.79 | 41.73 | ||
EBIT / Interest Expense | 1.87 | 6.6 | 22.77 | 21.09 | 20.16 | ||
EBITDA / Interest Expense | 2.6 | 8.15 | 27.54 | 25.31 | 24.79 | ||
(EBITDA - Capex) / Interest Expense | 0.98 | 1.47 | -1.19 | 8.31 | 3.35 | ||
Total Debt / EBITDA | 8.19 | 0.01 | 1.94 | 1.46 | 2.55 | ||
Net Debt / EBITDA | 6.6 | -6.57 | 0.2 | 0.46 | 1.84 | ||
Total Debt / (EBITDA - Capex) | 21.61 | 0.04 | -44.93 | 4.45 | 18.86 | ||
Net Debt / (EBITDA - Capex) | 17.43 | -36.39 | -4.64 | 1.4 | 13.63 | ||
Growth Over Prior Year | |||||||
Total Revenues, 1 Yr. Growth % | 41.73 | 29.1 | 65.17 | 38.02 | 27.57 | ||
Gross Profit, 1 Yr. Growth % | 38.34 | 45.41 | 57.78 | 36.58 | 24.56 | ||
EBITDA, 1 Yr. Growth % | 72.09 | 58.89 | 61.84 | 39.25 | 21.01 | ||
EBITA, 1 Yr. Growth % | 78.37 | 77.01 | 65.2 | 39.83 | 18.27 | ||
EBIT, 1 Yr. Growth % | 80.37 | 78.1 | 65.22 | 39.98 | 18.29 | ||
Earnings From Cont. Operations, 1 Yr. Growth % | 1.54K | 345.25 | 155.96 | 6.33 | 42.14 | ||
Net Income, 1 Yr. Growth % | 1.44K | 327.7 | 159.55 | 8 | 43.24 | ||
Normalized Net Income, 1 Yr. Growth % | 320.05 | 191.84 | 92.15 | 43.33 | 17.38 | ||
Diluted EPS Before Extra, 1 Yr. Growth % | 1.92K | 175.44 | 86.84 | 8.45 | 40.26 | ||
Accounts Receivable, 1 Yr. Growth % | 30.02 | 31.65 | 69.13 | 34.43 | 44.66 | ||
Inventory, 1 Yr. Growth % | 1.07 | 11.45 | 128 | 49.76 | 36.87 | ||
Net Property, Plant and Equip., 1 Yr. Growth % | 5.28 | 21.68 | 84.29 | 19.14 | 54.41 | ||
Total Assets, 1 Yr. Growth % | 11.64 | 112.42 | 42.24 | 8.3 | 48.23 | ||
Tangible Book Value, 1 Yr. Growth % | 2.27 | -760.33 | -46.58 | 22.87 | -10.3 | ||
Common Equity, 1 Yr. Growth % | 5.6 | -2.21K | 4.42 | 10.71 | 26.34 | ||
Cash From Operations, 1 Yr. Growth % | 42.94 | 29.53 | 43.94 | 60.79 | 14.22 | ||
Capital Expenditures, 1 Yr. Growth % | -46.38 | 108.69 | 106 | -10.55 | 56.07 | ||
Levered Free Cash Flow, 1 Yr. Growth % | -76.02 | 157.29 | -117.61 | -757.97 | -178.37 | ||
Unlevered Free Cash Flow, 1 Yr. Growth % | -96.42 | 1.63K | -131.2 | -500.15 | -202.7 | ||
Compound Annual Growth Rate Over Two Years | |||||||
Total Revenues, 2 Yr. CAGR % |